RISK-BASED SCREENING FOR CERVICAL CANCER

CORDIS fournit des liens vers les livrables publics et les publications des projets HORIZON.

Les liens vers les livrables et les publications des projets du 7e PC, ainsi que les liens vers certains types de résultats spécifiques tels que les jeux de données et les logiciels, sont récupérés dynamiquement sur OpenAIRE .

Livrables

e-Survey software platform

eSurvey software platform Beta release of eSurvey platform including mobile app for Android and iOS platforms and Backend system for the management of users participant consents studies and associated data The release is for testing purposes The software will be available as opensource through GitHub

report on published results

Report on published results, including details on data access

Webiste available online details on data access

Website available online

Validated microsimulation and open-source model

Validated microsimulation and open-source model of multiple oncogenic HPV infection progression to cervical cancer designed to compare the effectiveness and cost-effectiveness of different cervical cancer screening algorithms adapted to specific risk profiles.

Integrated e-Health / m-Healt platform

Integrated e-Health/m-Health platform: Integration of e-Consent/e-Survey platform with the data analysis platform

Publications

Assessment of Human Papillomavirus Non-16/18, Type-Specific Risk for Cervical Intraepithelial Neoplasia Grade 3 or Worse Among Women With Cervical Atypical Glandular Cells.

Auteurs: Yilmaz, E., Lagheden, C., Ghaderi, M., Wang, J., Dillner, J., & Elfström, K. M.
Publié dans: Obstetrics & Gynecology,, 2023, Page(s) 142(3), 679., ISSN 0029-7844
Éditeur: Lippincott Williams & Wilkins Ltd.
DOI: 10.1097/aog.0000000000005286

Accuracy of High-Risk HPV DNA PCR, P16(INK4a) Immunohistochemistry or the Combination of Both to Diagnose HPV-Driven Oropharyngeal Cancer

Auteurs: Cindy Simoens, Tarik Gheit, Ruediger Ridder, Ivana Gorbaslieva, Dana Holzinger, Eric Lucas, Susanne Rehm, Peter Vermeulen, Martin Lammens, Olivier M. Vanderveken, Rekha Vijay Kumar, Nitin Gangane, Alessandro Caniglia, Fausto Maffini, Maria Belén Lloveras Rubio, Devasena Anantharaman, Susanna Chiocca, Paul Brennan, Madhavan Radhakrishna Pillai, Rengaswamy Sankaranarayanan, Johannes Bogers, Michael
Publié dans: BMC Infectious Diseases, Numéro 22, 2022, Page(s) 676, ISSN 1471-2334
Éditeur: BioMed Central
DOI: 10.1186/s12879-022-07654-2

Benefits and harms of cervical screening, triage and treatment strategies in women living with HIV

Auteurs: Hall, M. T., Simms, K. T., Murray, J. M., Keane, A., Nguyen, D. T. N., Caruana, M., Lui, G., Kelly, H., Eckert, L. O., Santesso, N., de Sanjose, S., Swai, E. E., Rangaraj, A., Owiredu, M. N., Gauvreau, C., Demke, O., Basu, P., Arbyn, M., Dalal, S., … Canfell, K.
Publié dans: Nature Medicine, 2023, Page(s) 29(12), Article 12., ISSN 1078-8956
Éditeur: Nature Publishing Group
DOI: 10.1038/s41591-023-02601-3

Prospective Longitudinal Study of Dynamics of Human Papillomavirus 6 and 11 Infection in Anogenital Hairs and Eyebrows of Male Patients with Anogenital Warts and Age-Matched Controls

Auteurs: Vesna Tlaker, Lea Hošnjak, Mateja Kolenc, Tomaž Mark Zorec, Boštjan Luzar, Marko Potočnik, Jovan Miljković, Katja Seme, Mario Poljak
Publié dans: Microorganisms, Numéro 12, 2024, Page(s) 466, ISSN 2076-2607
Éditeur: MDPI
DOI: 10.3390/microorganisms12030466

Clinical Performance of Triage Strategies for Hr-HPV–Positive Women; A Longitudinal Evaluation of Cytology, p16/K-67 Dual Stain Cytology, and HPV16/18 Genotyping

Auteurs: Grazyna Stanczuk, Heather Currie, William Forson, Gwendoline Baxter, James Lawrence, Allan Wilson, Timothy Palmer, Marc Arbyn, Kate Cuschieri
Publié dans: Cancer Epidemiology, Biomarkers & Prevention, Numéro 31, 2022, Page(s) 1492-1498, ISSN 1055-9965
Éditeur: American Association for Cancer Research
DOI: 10.1158/1055-9965.epi-21-1425

Clinical Regression of High-Grade Cervical Intraepithelial Neoplasia Is Associated With Absence of FAM19A4/miR124-2 DNA Methylation (CONCERVE Study)

Auteurs: Wieke W. Kremer, Stèfanie Dick, Daniëlle A.M. Heideman, Renske D.M. Steenbergen, Maaike C.G. Bleeker, Harold R. Verhoeve, W. Marchien van Baal, Nienke van Trommel, Gemma G. Kenter, Chris J.L.M. Meijer, Johannes Berkhof
Publié dans: Journal of Clinical Oncology, Numéro 40, 2022, Page(s) 3037-3046, ISSN 0732-183X
Éditeur: American Society of Clinical Oncology
DOI: 10.1200/jco.21.02433

Pricing of HPV Tests in Italian Tender-Based Settings

Auteurs: Federica Inturrisi and Johannes Berkhof
Publié dans: Journal of Medical Economics, Numéro 25(1), 2022, Page(s) 762–68, ISSN 1369-6998
Éditeur: P J B Publications Ltd.
DOI: 10.1080/13696998.2022.2082777

Comparison and validation of metadta for meta‐analysis of diagnostic test accuracy studies

Auteurs: Victoria N. Nyaga, Marc Arbyn
Publié dans: Research Synthesis Methods, Numéro 14, 2023, Page(s) 544-562, ISSN 1759-2887
Éditeur: John Wiley & Sons
DOI: 10.1002/jrsm.1634

Cervical Cancer Screening Using HPV Tests on Self-Samples: Attitudes and Preferences of Women Participating in the VALHUDES Study

Auteurs: Hélène De Pauw, Gilbert Donders, Steven Weyers, Philippe De Sutter, Jean Doyen, Wiebren A. A. Tjalma, Davy Vanden Broeck, Eliana Peeters, Severien Van Keer, Alex Vorsters, and Marc Arbyn
Publié dans: Archives of Public Health, Numéro 79, 2021, Page(s) 155, ISSN 0778-7367
Éditeur: London BioMed Central
DOI: 10.1186/s13690-021-00667-4

Different skin wart types, different human papillomavirus types? A narrative review

Auteurs: Lucijan Skubic, Vesna Breznik, Mario Poljak
Publié dans: Acta Dermatovenerologica Alpina Pannonica et Adriatica, Numéro 32, 2024, ISSN 1318-4458
Éditeur: Dermatovenerological Society of Slovenia
DOI: 10.15570/actaapa.2023.30

Offering HPV self-sampling kits: an updated meta-analysis of the effectiveness of strategies to increase participation in cervical cancer screening

Auteurs: Stefanie Costa, Bo Verberckmoes, Philip E. Castle, Marc Arbyn
Publié dans: British Journal of Cancer, Numéro 128, 2023, Page(s) 805-813, ISSN 0007-0920
Éditeur: Nature Publishing Group
DOI: 10.1038/s41416-022-02094-w

Cervical cancer prevention in transgender men: A review.

Auteurs: Weyers, S., Garland, S. M., Cruickshank, M., Kyrgiou, M., & Arbyn, M.
Publié dans: BJOG: An International Journal of Obstetrics and Gynaecology,, 2021, Page(s) 128(5), 822-826, ISSN 1470-0328
Éditeur: Blackwell Publishing Inc.
DOI: 10.1111/1471-0528.16503

Clinical performance of high-risk HPV testing on self-samples versus clinician samples in routine primary HPV screening in the Netherlands: An observational study

Auteurs: Federica Inturrisi, Clare A. Aitken, Willem J.G. Melchers, Adriaan J.C. van den Brule, Anco Molijn, John W.J. Hinrichs, Hubert G.M. Niesters, Albert G. Siebers, Rob Schuurman, Daniëlle A.M. Heideman, Inge M.C.M. de Kok, Ruud L.M. Bekkers, Folkert J. van Kemenade, Johannes Berkhof
Publié dans: The Lancet Regional Health - Europe, Numéro 11, 2021, Page(s) 100235, ISSN 2666-7762
Éditeur: Elsevier BV
DOI: 10.1016/j.lanepe.2021.100235

Cervical cancer screening improvements with self-sampling during the COVID-19 pandemic

Auteurs: Miriam Elfström; Penelope Grace Gray; Joakim Dillner
Publié dans: eLife,, Numéro Vol 12 (2023)1, 2023, ISSN 2050-084X
Éditeur: eLife Sciences Publications
DOI: 10.7554/elife.80905

Increasing Global Accessibility to High-Level Treatments for Cervical Cancers

Auteurs: Chargari, C., M. Arbyn, A. Leary, N. R. Abu-Rustum, P. Basu, F. Bray, S. Chopra, R. Nout, K. Tanderup, A. N. Viswanathan, C. Zacharopoulou, J. C. Soria, E. Deutsch, S. Gouy, and P. Morice
Publié dans: Gynecologic Oncology, Numéro 231–41, 2022, Page(s) 164(1), ISSN 0090-8258
Éditeur: Academic Press
DOI: 10.1016/j.ygyno.2021.10.073

Intra‐ and interlaboratory reproducibility evaluation toward international validation status of the AmpFire assay

Auteurs: Pui Yan Jenny Chung, Sharonjit K. Dhillon, Alice Baraquin, Yuliya Tkachenka, Killian Jacquot, Jean‐Luc Prétet, Davy Vanden Broeck, Marc Arbyn
Publié dans: Journal of Medical Virology, Numéro 96, 2024, ISSN 0146-6615
Éditeur: John Wiley & Sons Inc.
DOI: 10.1002/jmv.29688

Nationwide registry‐based trial of risk‐stratified cervical screening

Auteurs: Laila Sara Arroyo Mühr, Jiangrong Wang, Sadaf S. Hassan, Emel Yilmaz, Miriam K. Elfström, Joakim Dillner
Publié dans: International Journal of Cancer, Numéro 156, 2024, Page(s) 379-388, ISSN 0020-7136
Éditeur: John Wiley & Sons Inc.
DOI: 10.1002/ijc.35142

Can HPV Selfy Be Considered as a Clinically Validated HPV Test for Use in Cervical Cancer Screening?

Auteurs: Marc Arbyn, Jesper Bonde, Kate Cushieri, and Mario Poljak
Publié dans: Journal of Translational Medicine, Numéro 20, 2022, Page(s) 422, ISSN 1479-5876
Éditeur: BioMed Central
DOI: 10.1186/s12967-022-03627-w

Clinical Performance of the Full Genotyping Agena MassARRAY HPV Assay Using SurePath Screening Samples within the VALGENT4 Framework

Auteurs: Helle Pedersen, Ditte M. Ejegod, Wim Quint, Lan Xu, Marc Arbyn, and Jesper Bonde
Publié dans: The Journal of Molecular Diagnostics, Numéro JMD 24(4), 2022, Page(s) 365–73, ISSN 1525-1578
Éditeur: American Society for Investigative Pathology
DOI: 10.1016/j.jmoldx.2021.12.009

Triage of HPV-positive women in Norway using cytology, HPV16/18 genotyping and HPV persistence

Auteurs: Marc Arbyn, Remila Rezhake, Susan Yuill, Karen Canfell
Publié dans: British Journal of Cancer, Numéro 122/11, 2020, Page(s) 1577-1579, ISSN 0007-0920
Éditeur: Nature Publishing Group
DOI: 10.1038/s41416-020-0787-9

Acceptance of Self-Sampling by Women Not Regularly Participating in Cervical Cancer Screening in Areas with Low Medical Density: A Qualitative Study within the French CapU4 Trial

Auteurs: Johane Le Goff, Anne-Sophie Le Duc-Banaszuk, Caroline Lefeuvre, Adeline Pivert, Alexandra Ducancelle, Hélène De Pauw, Marc Arbyn, Aubeline Vinay, Franck Rexand-Galais
Publié dans: Cancers, Numéro 16, 2025, Page(s) 2066, ISSN 2072-6694
Éditeur: Multidisciplinary Digital Publishing Institute (MDPI)
DOI: 10.3390/cancers16112066

Validation of BD Onclarity HPV Assay on Vaginal Self-Samples versus Cervical Samples Using the VALHUDES Protocol

Auteurs: Ardashel Latsuzbaia, Davy Vanden Broeck, Severien Van Keer, Steven Weyers, Gilbert Donders, Jean Doyen, Wiebren Tjalma, Philippe De Sutter, Eliana Peeters, Alex Vorsters, Marc Arbyn
Publié dans: Cancer Epidemiology, Biomarkers & Prevention, Numéro 31, 2023, Page(s) 2177-2184, ISSN 1055-9965
Éditeur: American Association for Cancer Research
DOI: 10.1158/1055-9965.epi-22-0757

Risk of Cervical Precancer among HPV–Negative Women in the Netherlands and Its Association with Previous HPV and Cytology Results: A Follow-up Analysis of a Randomized Screening Study

Auteurs: Federica Inturrisi, Lawrence Rozendaal, Nienke J. Veldhuijzen, Daniëlle A. M. Heideman, Chris J. L. M. Meijer, and Johannes Berkhof
Publié dans: PLOS Medicine, Numéro 19(10), 2022, Page(s) e1004115, ISSN 1549-1277
Éditeur: Public Library of Science
DOI: 10.1371/journal.pmed.1004115

An International Consensus on the Essential and Desirable Criteria for an ‘Organized’ Cancer Screening Programme

Auteurs: Li Zhang André L. Carvalho, Isabel Mosquera, Tianmeng Wen, Eric Lucas, Catherine Sauvaget, Richard Muwonge, Marc Arbyn, Elisabete Weiderpass, and Partha Basu
Publié dans: BMC Medicine, Numéro 20(1), 2022, Page(s) 101, ISSN 1741-7015
Éditeur: BioMed Central
DOI: 10.1186/s12916-022-02291-7

Clinical Performance of the RealTime High Risk HPV Assay on Self-Collected Vaginal Samples within the VALHUDES Framework

Auteurs: Ardashel Latsuzbaia, Davy Vanden Broeck, Severien Van Keer, Steven Weyers, Wiebren A. A. Tjalma, Jean Doyen, Gilbert Donders, Philippe De Sutter, Alex Vorsters, Eliana Peeters, and Marc Arbyn
Publié dans: Microbiology Spectrum, Numéro 10(5), 2022, Page(s) e01631-22, ISSN 2165-0497
Éditeur: ASM International
DOI: 10.1128/spectrum.01631-22

HPV Testing of Self-Samples: Influence of Collection and Sample Handling Procedures on Clinical Accuracy to Detect Cervical Precancer

Auteurs: Marc Arbyn, Ardashel Latsuzbaia, Philip E. Castle, Vikrant V. Sahasrabuddhe, and Davy Vanden Broeck
Publié dans: The Lancet Regional Health – Europe, Numéro 14, 2022, ISSN 2666-7762
Éditeur: Oxford: Elsevier Ltd.
DOI: 10.1016/j.lanepe.2022.100332

Clinical Evaluation of P16INK4a Immunocytology in Cervical Cancer Screening: A Population-Based Cross-Sectional Study from Rural China

Auteurs: Remila Rezhake, Yan Wang, Feng Chen, Shang-Ying Hu, Xun Zhang, Jian Cao, You-Lin Qiao, Fang-Hui Zhao, and Marc Arbyn
Publié dans: Cancer Cytopathology, Numéro 129(9), 2021, Page(s) 679–92, ISSN 1934-662X
Éditeur: Wiley-Blackwell
DOI: 10.1002/cncy.22428

Evaluation of the clinical performance of OncoPredict HPV® SCR assay within the VALGENT‐2 framework

Auteurs: Sharonjit K. Dhillon, Clementina E. Cocuzza, Pui Yan Jenny Chung, Marianna Martinelli, Chiara Giubbi, Ruth C. Njoku, Ramya Bhatia, Kate Cuschieri, Marc Arbyn
Publié dans: Journal of Medical Virology, Numéro 95, 2024, ISSN 0146-6615
Éditeur: John Wiley & Sons Inc.
DOI: 10.1002/jmv.28417

Papilloplex HR-HPV Test Has Non-Inferior Clinical Performance for Detection of Human Papillomavirus Infection: Assessment Using the VALGENT Framework

Auteurs: Ramya Bhatia, Elia Alcaniz Boada, Jesper Hansen Bonde, Wim G. V. Quint, Lan Xu, Ditte Moller Ejegod, Kate Cuschieri, and Marc Arbyn
Publié dans: Journal of Clinical Pathology, Numéro 2021-11-15, 2021, ISSN 0021-9746
Éditeur: BMJ Publishing Group
DOI: 10.1136/jclinpath-2021-207864

Meta‐analysis of agreement/concordance statistics in studies comparing self‐ vs clinician‐collected samples for <scp>HPV</scp> testing in cervical cancer screening

Auteurs: Marc Arbyn, Philip E. Castle, Mark Schiffman, Nicolas Wentzensen, Brandy Heckman‐Stoddard, Vikrant V. Sahasrabuddhe
Publié dans: International Journal of Cancer, Numéro 151, 2023, Page(s) 308-312, ISSN 0020-7136
Éditeur: John Wiley & Sons Inc.
DOI: 10.1002/ijc.33967

Assessing the risk of cervical neoplasia in the post-HPV vaccination era

Auteurs: Lehtinen, Matti; Pimenoff, Ville N.; Nedjai, Belinda; Louvanto, Karolina; Verhoef, Lisanne; Heideman, Daniëlle A.M.; El-Zein, Mariam; Widschwendter, Martin; Dillner, Joakim
Publié dans: Int J Cancer, Numéro 26, 2023, ISSN 0020-7136
Éditeur: John Wiley & Sons Inc.
DOI: 10.1002/ijc.34286

Human papillomavirus negative high grade cervical lesions and cancers: Suggested guidance for HPV testing quality assurance

Auteurs: Jean Luc Prétet, Laila Sara Arroyo Mühr, Kate Cuschieri, María Dolores Fellner, Rita Mariel Correa, María Alejandra Picconi, Suzanne M. Garland, Gerald L. Murray, Monica Molano, Michael Peeters, Steven Van Gucht, Charlotte Lambrecht, Davy Vanden Broeck, Elizaveta Padalko, Marc Arbyn, Quentin Lepiller, Alice Brunier, Steffi Silling, Kristiane Søreng, Irene Kraus Christiansen, Mario Poljak, Cam
Publié dans: Journal of Clinical Virology, Numéro 171, 2024, Page(s) 105657, ISSN 1386-6532
Éditeur: Elsevier BV
DOI: 10.1016/j.jcv.2024.105657

Global Estimates of Expected and Preventable Cervical Cancers among Girls Born between 2005 and 2014: A Birth Cohort Analysis.

Auteurs: Maxime Bonjour, Hadrien Charvat, Eduardo L. Franco, Marion Piñeros, Gary M. Clifford, Freddie Bray, and Iacopo Baussano
Publié dans: The Lancet Public Health, Numéro 6(7), 2021, Page(s) e510–2, ISSN 2468-2667
Éditeur: London: Elsevier Ltd.
DOI: 10.1016/s2468-2667(21)00046-3

European Federation for Colposcopy (EFC) and European Society of Gynaecological Oncology (ESGO) joint considerations about human papillomavirus (HPV) vaccination, screening programs, colposcopy, and surgery during and after the COVID-19 pandemic

Auteurs: Andrea Ciavattini, Giovanni Delli Carpini, Luca Giannella, Marc Arbyn, Maria Kyrgiou, Elmar A Joura, Jalid Sehouli, Xavier Carcopino, Charles W Redman, Pekka Nieminen, Maggie Cruickshank, Murat Gultekin
Publié dans: International Journal of Gynecologic Cancer, Numéro 30, 2024, Page(s) 1097-1100, ISSN 1048-891X
Éditeur: Blackwell Publishing Inc.
DOI: 10.1136/ijgc-2020-001617

Scientific approaches toward improving cervical cancer elimination strategies

Auteurs: Matti Lehtinen, Laia Bruni, Miriam Elfström, Penelope Gray, Margaret Logel, Filipe Colaço Mariz, Iacopo Baussano, Simopekka Vänskä, Eduardo L. Franco, Joakim Dillner
Publié dans: International Journal of Cancer, Numéro 154, 2024, Page(s) 1537-1548, ISSN 0020-7136
Éditeur: John Wiley & Sons Inc.
DOI: 10.1002/ijc.34839

Assessment of Acceptability and Determinants of Uptake and Schedule Completion of Human Papillomavirus (HPV) Vaccine by 25 to 45 Years Old Women in Slovenia

Auteurs: Jana Mlakar; Anja Oštrbenk Valenčak; Jožefa Kežar; Lara Beseničar-Pregelj; Mario Poljak
Publié dans: Vaccines, Numéro 18, 2023, ISSN 2076-393X
Éditeur: Multidisciplinary Digital Publishing Institute (MDPI)
DOI: 10.3390/vaccines11020423

Head-to-Head Comparison of Bi- and Nonavalent Human Papillomavirus Vaccine-Induced Antibody Responses

Auteurs: Arroyo Mühr, Laila Sara, Carina Eklund, Camilla Lagheden, Tiina Eriksson, Ville N. Pimenoff, Penelope Gray, Matti Lehtinen, and Joakim Dillner
Publié dans: The Journal of Infectious Diseases, Numéro 226(7), 2022, Page(s) 1195–99, ISSN 0022-1899
Éditeur: University of Chicago Press
DOI: 10.1093/infdis/jiac190

Comparison of the Clinical Accuracy of Xpert HPV Assay on Vaginal Self-Samples and Cervical Clinician-Taken Samples within the VALHUDES Framework

Auteurs: Ardashel Latsuzbaia, Davy Vanden Broeck, Severien Van Keer, Steven Weyers, Gilbert Donders, Jean Doyen, Wiebren Tjalma, Philippe De Sutter, Alex Vorsters, Marc Arbyn
Publié dans: The Journal of Molecular Diagnostics, Numéro 25, 2023, Page(s) 702-708, ISSN 1525-1578
Éditeur: American Society for Investigative Pathology
DOI: 10.1016/j.jmoldx.2023.06.004

Global Estimates of Incidence and Mortality of Cervical Cancer in 2020: A Baseline Analysis of the WHO Global Cervical Cancer Elimination Initiative

Auteurs: Deependra Singh, Jerome Vignat, Valentina Lorenzoni, Marzieh Eslahi, Ophira Ginsburg, Beatrice Lauby-Secretan, Marc Arbyn, Partha Basu, Freddie Bray, and Salvatore Vaccarella
Publié dans: The Lancet Global Health, Numéro 11(2), 2023, Page(s) e197–206, ISSN 2214-109X
Éditeur: Elsevier BV
DOI: 10.1016/s2214-109x(22)00501-0

Analytical and clinical performance of extended HPV genotyping with BD Onclarity HPV Assay in home-collected first-void urine: A diagnostic test accuracy study

Auteurs: Severien Van Keer; Ardashel Latsuzbaia; Davy Vanden Broeck; Philippe De Sutter; Gilbert Donders; Jean Doyen; Wiebren A.A. Tjalma; Steven Weyers; Marc Arbyn; Alex Vorsters
Publié dans: Journal of Clinical Virology, 2022, ISSN 1386-6532
Éditeur: Elsevier BV
DOI: 10.1016/j.jcv.2022.105271

Accuracy of HPV E6/E7 oncoprotein tests to detect high-grade cervical lesions: A systematic literature review and meta-analysis.

Auteurs: Downham, L., Jaafar, I., Rol, M. L., Nyawira Nyaga, V., Valls, J., Baena, A., Zhang, L., Gunter, M. J., Arbyn, M., & Almonte, M.
Publié dans: British Journal of Cancer, 2023, Page(s) 1-9., ISSN 0007-0920
Éditeur: Nature Publishing Group
DOI: 10.1038/s41416-023-02490-w

Performance of <scp>DNA</scp> methylation analysis of <scp>ASCL1</scp>, <scp>LHX8</scp>, <scp>ST6GALNAC5</scp>, <scp>GHSR</scp>, <scp>ZIC1</scp> and <scp>SST</scp> for the triage of <scp>HPV</scp>‐positive women: Results from a Dutch primary <scp>HPV</scp>‐based screening cohort

Auteurs: Lisanne Verhoef; Maaike C. G. Bleeker; Nicole Polman; Renske D. M. Steenbergen; Chris J. L. M. Meijer; Willem J. G. Melchers; Ruud L. Bekkers; Anco C. Molijn; Wim G. Quint; Folkert J. van Kemenade; Johannes Berkhof; Daniëlle A. M. Heideman
Publié dans: Int J Cancer, 2024, ISSN 0020-7136
Éditeur: John Wiley & Sons Inc.
DOI: 10.1002/ijc.33820

Colposcopy Referral and CIN3+ Risk of Human Papillomavirus Genotyping Strategies in Cervical Cancer Screening

Auteurs: Kelsi R. Kroon, Johannes A. Bogaards, Daniëlle A.M. Heideman, Chris J.L.M. Meijer, Johannes Berkhof
Publié dans: Cancer Epidemiology, Biomarkers & Prevention, Numéro 33, 2024, Page(s) 1037-1045, ISSN 1055-9965
Éditeur: American Association for Cancer Research
DOI: 10.1158/1055-9965.epi-24-0046

Worldwide use of HPV self-sampling for cervical cancer screening.

Auteurs: Serrano B, Ibáñez R, Robles C, Peremiquel-Trillas P, de Sanjosé S, Bruni L.
Publié dans: Prev Med., Numéro 154, 2022, Page(s) 106900., ISSN 0091-7435
Éditeur: Academic Press
DOI: 10.1016/j.ypmed.2021.106900

Stratified Mucin-Producing Intraepithelial Lesion (SMILE) of the Uterine Cervix: High-Risk HPV Genotype Predominance and P40 Immunophenotype

Auteurs: Strojan Fležar, Margareta, Neža Nedelko, Mario Poljak, Anja Oštrbenk Valenčak, and Helena Gutnik
Publié dans: Cells, Numéro 10(8), 2021, Page(s) 2039, ISSN 2073-4409
Éditeur: Basel MDPI AG 2012-
DOI: 10.3390/cells10082039

Colposcopy referrals and <scp>CIN3</scp> detection after triage by host cell <scp>DNA</scp> methylation and/or <scp>HPV</scp> genotyping in <scp>HPV</scp> positive women with low‐grade cytology from a population‐based Dutch primary <scp>HPV</scp> screening trial

Auteurs: Lisanne Verhoef, Maaike C. G. Bleeker, Nicole Polman, Kelsi R. Kroon, Renske D. M. Steenbergen, Renée M. F. Ebisch, Willem J. G. Melchers, Ruud L. M. Bekkers, Anco C. Molijn, Folkert van Kemenade, Chris J. L. M. Meijer, Daniëlle A. M. Heideman, Johannes Berkhof
Publié dans: International Journal of Cancer, Numéro 156, 2025, Page(s) 1065-1073, ISSN 0020-7136
Éditeur: John Wiley & Sons Inc.
DOI: 10.1002/ijc.35289

Clinical Accuracy of Alinity m HR HPV Assay on Self- versus Clinician-Taken Samples Using the VALHUDES Protocol

Auteurs: Ardashel Latsuzbaia, Severien Van Keer, Davy Vanden Broeck, Steven Weyers, Gilbert Donders, Philippe De Sutter, Wiebren Tjalma, Jean Doyen, Alex Vorsters, Marc Arbyn
Publié dans: The Journal of Molecular Diagnostics, Numéro 25, 2024, Page(s) 957-966, ISSN 1525-1578
Éditeur: American Society for Investigative Pathology
DOI: 10.1016/j.jmoldx.2023.09.008

Women with a Positive High-Risk Human Papillomavirus (HPV) Test Remain at Increased Risk of HPV Infection and Cervical Precancer ≥15 Years Later

Auteurs: Federica Inturrisi, Johannes A. Bogaards, Albert G. Siebers, Chris J. L. M. Meijer, Daniëlle A. M. Heideman, and Johannes Berkhof
Publié dans: Tumour Virus Research, Numéro 14, 2022, Page(s) 200240, ISSN 2666-6790
Éditeur: Amsterdam: Elsevier B.V.
DOI: 10.1016/j.tvr.2022.200240

Cervical cancer screening coverage in the Americas region: A synthetic analysis.

Auteurs: Fernández-Deaza, G., Serrano, B., Roura, E., Castillo, J. S., Caicedo-Martínez, M., Bruni, L., & Murillo, R.
Publié dans: The Lancet Regional Health – Americas, 2024, ISSN 2667-193X
Éditeur: Oxford Elsevier Ltd.
DOI: 10.1016/j.lana.2024.100689

Myths and Fake Messages about Human Papillomavirus (HPV) Vaccination: Answers from the ESGO Prevention Committee

Auteurs: Nadja Taumberger, Elmar A. Joura, Marc Arbyn, Maria Kyrgiou, Jalid Sehouli, and Murat Gultekin
Publié dans: International Journal of Gynecological Cancer, Numéro 32(10), 2022, Page(s) 1316–20, ISSN 1048-891X
Éditeur: Blackwell Publishing Inc.
DOI: 10.1136/ijgc-2022-003685

Concomitant human papillomavirus (HPV) vaccination and screening for elimination of HPV and cervical cancer

Auteurs: Laila Sara Arroyo Mühr, Andrea Gini, Emel Yilmaz, Sadaf S. Hassan, Camilla Lagheden, Emilie Hultin, Ainhoa Garcia Serrano, Agustin E. Ure, Helena Andersson, Roxana Merino, K. Miriam Elfström, Iacopo Baussano, Joakim Dillner
Publié dans: Nature Communications, Numéro 15, 2024, ISSN 2041-1723
Éditeur: Nature Publishing Group
DOI: 10.1038/s41467-024-47909-x

Benefits, harms and cost-effectiveness of cervical screening, triage and treatment strategies for women in the general population.

Auteurs: Simms, K. T., Keane, A., Nguyen, D. T. N., Caruana, M., Hall, M. T., Lui, G., Gauvreau, C., Demke, O., Arbyn, M., Basu, P., Wentzensen, N., Lauby-Secretan, B., Ilbawi, A., Hutubessy, R., Almonte, M., De Sanjosé, S., Kelly, H., Dalal, S., Eckert, L. O., … Canfell, K.
Publié dans: Nature Medicine, 2023, Page(s) 29(12), Article 12., ISSN 1078-8956
Éditeur: Nature Publishing Group
DOI: 10.1038/s41591-023-02600-4

The ESSAG-trial protocol: A randomized controlled trial evaluating the efficacy of offering a self-sampling kit by the GP to reach women underscreened in the routine cervical cancer screening program

Auteurs: Eva Gezels, Kaatje Van Roy, Marc Arbyn, Patrick Coursier, Dirk Devroey, Patrick Martens, Cindy Simoens, Bert Vaes, Koen Van Herck, Patrick Vankrunkelsven, Veronique Verhoeven, Sara Willems
Publié dans: Contemporary Clinical Trials, Numéro 144, 2024, Page(s) 107617, ISSN 1551-7144
Éditeur: Elsevier BV
DOI: 10.1016/j.cct.2024.107617

Comparative Effectiveness and Risk of Preterm Birth of Local Treatments for Cervical Intraepithelial Neoplasia and Stage IA1 Cervical Cancer: A Systematic Review and Network Meta-Analysis

Auteurs: Antonios Athanasiou, Areti Angeliki Veroniki, Orestis Efthimiou, Ilkka Kalliala, Huseyin Naci, Sarah Bowden, Maria Paraskevaidi, Marc Arbyn, Deirdre Lyons, Pierre Martin-Hirsch, Phillip Bennett, Evangelos Paraskevaidis, Georgia Salanti, and Maria Kyrgiou
Publié dans: The Lancet. Oncology, Numéro 23(8), 2022, Page(s) 1097–1108, ISSN 1470-2045
Éditeur: The Lancet Publishing Group
DOI: 10.1016/s1470-2045(22)00334-5

The Impact of HPV Vaccination beyond Cancer Prevention: Effect on Pregnancy Outcomes

Auteurs: Susan Yuill, Louiza S. Velentzis, Megan Smith, Sam Egger, C. David Wrede, Deborah Bateson, Marc Arbyn, and Karen Canfell
Publié dans: Human Vaccines & Immunotherapeutics, Numéro 17(10), 2021, Page(s) 3562–76, ISSN 2164-5515
Éditeur: Landes Bioscience
DOI: 10.1080/21645515.2021.1936860

Linkage of individual-patient data confirm protection of prophylactic human papillomavirus vaccination against invasive cervical cancer

Auteurs: Marc Arbyn, Pegah Rousta, Laia Bruni, Lina Schollin Ask, Partha Basu
Publié dans: JNCI: Journal of the National Cancer Institute, Numéro 116, 2024, Page(s) 775-778, ISSN 0027-8874
Éditeur: Oxford University Press
DOI: 10.1093/jnci/djae042

Impact of cervical screening by human papillomavirus genotype: Population-based estimations

Auteurs: Jiangrong Wang, K. Miriam Elfström, Camilla Lagheden, Carina Eklund, Karin Sundström, Pär Sparén, Joakim Dillner
Publié dans: PLOS Medicine, Numéro 20, 2023, Page(s) e1004304, ISSN 1549-1676
Éditeur: PLoS Medicin
DOI: 10.1371/journal.pmed.1004304

Validation of the clinical performance and reproducibility of the NeumoDX HPV assay self-sample workflow.

Auteurs: Heideman, D. A. M., Berkhof, J., Verhoef, L., Ouwerkerk, C., Smit, P. W., Oštrbenk Valenčak, A., Mlakar, J., Poljak, M., Steenbergen, R. D. M., & Bleeker, M. C. G.
Publié dans: Journal of Clinical Virology, 2024, Page(s) 105649, ISSN 1386-6532
Éditeur: Elsevier BV
DOI: 10.1016/j.jcv.2024.105649

A pilot study of risk-stratified cervical cancer screening

Auteurs: Jiangrong Wang, K. Miriam Elfström, Christer Borgfeldt, Joakim Dillner
Publié dans: Open Research Europe, Numéro 1, 2021, Page(s) 84, ISSN 2732-5121
Éditeur: EC
DOI: 10.12688/openreseurope.13398.1

Ecological diversity profiles of non-vaccine-targeted HPVs after gender-based community vaccination efforts

Auteurs: Ville N. Pimenoff, Penelope Gray, Karolina Louvanto, Tiina Eriksson, Camilla Lagheden, Anna Söderlund-Strand, Joakim Dillner, Matti Lehtinen
Publié dans: Cell Host & Microbe, Numéro 31, 2024, Page(s) 1921-1929.e3, ISSN 1931-3128
Éditeur: Cell Press
DOI: 10.1016/j.chom.2023.10.001

Efficacy of strategies to increase participation in cervical cancer screening: GPs offering self-sampling kits for HPV testing versus recommendations to have a pap smear taken - A randomised controlled trial

Auteurs: E. Peeters, K. Cornet, D. Devroey, M. Arbyn
Publié dans: Papillomavirus Research, Numéro 9, 2020, Page(s) 100194, ISSN 2405-8521
Éditeur: Elsevier
DOI: 10.1016/j.pvr.2020.100194

Low methylation marker levels among human papillomavirus‐vaccinated women with cervical high‐grade squamous intraepithelial lesions

Auteurs: Karolina Louvanto, Lisanne Verhoef, Ville Pimenoff, Tiina Eriksson, Siiri Leppälä, Camilla Lagheden, Penelope Gray, Dorota Scibior‐Bentkowska, Elizabeth Sumiec, Pekka Nieminen, Joakim Dillner, Johannes Berkhof, Chris J. L. M. Meijer, Matti Lehtinen, Belinda Nedjai, Daniëlle A. M. Heideman
Publié dans: International Journal of Cancer, 2024, ISSN 0020-7136
Éditeur: John Wiley & Sons Inc.
DOI: 10.1002/ijc.35044

Causal attribution of human papillomavirus genotypes to invasive cervical cancer worldwide: a systematic analysis of the global literature

Auteurs: Feixue Wei, Damien Georges, Irene Man, Iacopo Baussano, Gary M Clifford
Publié dans: The Lancet, Numéro 404, 2024, Page(s) 435-444, ISSN 0140-6736
Éditeur: The Lancet Publishing Group
DOI: 10.1016/s0140-6736(24)01097-3

Cervical Cancer Screening Programs in Latin America: Current Recommendations for Facing Elimination Challenges

Auteurs: Ginna Fernández-Deaza, Maria Caicedo-Martínez, Beatriz Serrano, Esther Roura, Juan Sebastián Castillo, Silvia de Sanjosé, Laia Bruni, and Raúl Murillo
Publié dans: Salud Pública de México, Numéro 64(4, jul-ago), 2022, Page(s) 415–23, ISSN 0036-3634
Éditeur: Instituto Nacional de Salud
DOI: 10.21149/13204

Clinical and analytical evaluation of the RealTime High Risk HPV assay in Colli-Pee collected first-void urine using the VALHUDES protocol

Auteurs: Severien Van Keer, Eliana Peeters, Davy Vanden Broeck, Philippe De Sutter, Gilbert Donders, Jean Doyen, Wiebren A.A. Tjalma, Steven Weyers, Alex Vorsters, Marc Arbyn
Publié dans: Gynecologic Oncology, Numéro 162, 2023, Page(s) 575-583, ISSN 0090-8258
Éditeur: Academic Press
DOI: 10.1016/j.ygyno.2021.06.010

Global and regional estimates of genital human papillomavirus prevalence among men: a systematic review and meta-analysis

Auteurs: Laia Bruni, Ginesa Albero, Jane Rowley, Laia Alemany, Marc Arbyn, Anna R Giuliano, Lauri E Markowitz, Nathalie Broutet, Melanie Taylor
Publié dans: The Lancet Global Health, Numéro 11, 2023, Page(s) e1345-e1362, ISSN 2214-109X
Éditeur: Elsevier BV
DOI: 10.1016/s2214-109x(23)00305-4

Comparison of the clinical and analytical performance of Alinity m HR HPV and cobas 4800 HPV assays in a population-based screening setting

Auteurs: Anja Oštrbenk Valenčak, Alexander Bertram, Arndt Gröning, Mario Poljak
Publié dans: Journal of Clinical Virology, Numéro 140, 2021, Page(s) 104851, ISSN 1386-6532
Éditeur: Elsevier BV
DOI: 10.1016/j.jcv.2021.104851

Impact of the COVID-19 pandemic on cervical cancer screening participation, abnormal cytology prevalence and screening interval in Catalonia

Auteurs: Claudia Robles, Laura Monfil, Raquel Ibáñez, Esther Roura, Rebeca Font, Paula Peremiquel-Trillas, Maria Brotons, Cristina Martínez-Bueno, Silvia de Sanjosé, Josep Alfons Espinàs, Laia Bruni
Publié dans: Frontiers in Oncology, Numéro 14, 2024, ISSN 2234-943X
Éditeur: Frontiers Media S. A.
DOI: 10.3389/fonc.2024.1338859

First international proficiency study on human papillomavirus testing in cervical cancer screening

Auteurs: Emel Yilmaz, Carina Eklund, Camilla Lagheden, Karin Dahlin Robertsson, Marina Lilja, Miriam Elfström, Laila Sara Arroyo Mühr, Joakim Dillner
Publié dans: Journal of Clinical Virology, Numéro 167, 2023, Page(s) 105581, ISSN 1386-6532
Éditeur: Elsevier BV
DOI: 10.1016/j.jcv.2023.105581

Cervical screening: ESGO-EFC position paper of the European Society of Gynaecologic Oncology (ESGO) and the European Federation of Colposcopy (EFC)

Auteurs: Maria Kyrgiou, Marc Arbyn, Christine Bergeron, F. Xavier Bosch, Joakim Dillner, Mark Jit, Jane Kim, Mario Poljak, Pekka Nieminen, Peter Sasieni, Vesna Kesic, Jack Cuzick, Murat Gultekin
Publié dans: British Journal of Cancer, Numéro 123/4, 2020, Page(s) 510-517, ISSN 0007-0920
Éditeur: Nature Publishing Group
DOI: 10.1038/s41416-020-0920-9

Metadta: A Stata Command for Meta-Analysis and Meta-Regression of Diagnostic Test Accuracy Data – a Tutorial

Auteurs: Victoria Nyawira Nyaga, and Marc Arbyn
Publié dans: Archives of Public Health, Numéro 80, 2022, Page(s) 95, ISSN 2049-3258
Éditeur: London BioMed Central
DOI: 10.1186/s13690-021-00747-5

IPVS policy statement on HPV nucleic acid testing guidance for those utilising/considering HPV as primary precancer screening: Quality assurance and quality control issues

Auteurs: Suzanne M. Garland, Thomas Iftner, Kate Cuschieri, Andreas M Kaufmann, Marc Arbyn, Silvia de Sanjose, Mario Poljak, Joakim Dillner, Elizabeth R. Unger, Suzanne M Garland, Margaret Stanley, Anna-Barbara Moscicki, Yin Ling Woo, Neerja Bhatla, Karen L. Chan, Joel Palefsky, Anna R Giuliano, Andreas M Kaufmann, Silvia de Sanjose, Julia M.L. Brotherton, Sarah Feldman
Publié dans: Journal of Clinical Virology, Numéro 159, 2023, Page(s) 105349, ISSN 1386-6532
Éditeur: Elsevier BV
DOI: 10.1016/j.jcv.2022.105349

Updated Evidence-Based Recommendations for Cervical Cancer Screening in France

Auteurs: Françoise F. Hamers, Anne-Isabelle Poullié, and Marc Arbyn
Publié dans: European Journal of Cancer Prevention, Numéro 31(3), 2022, Page(s) 279–86, ISSN 0959-8278
Éditeur: Lippincott Williams & Wilkins Ltd.
DOI: 10.1097/cej.0000000000000701

Risk-stratification of HPV-positive women with low-grade cytology by FAM19A4/miR124-2 methylation and HPV genotyping

Auteurs: Stèfanie Dick, Frederique J. Vink, Daniëlle A. M. Heideman, Birgit I. Lissenberg-Witte, Chris J. L. M. Meijer, Johannes Berkhof
Publié dans: British Journal of Cancer, Numéro 126, 2022, Page(s) 259-264, ISSN 0007-0920
Éditeur: Nature Publishing Group
DOI: 10.1038/s41416-021-01614-4

Clinical Validation of the Onclarity Assay After Assay Migration to the High-Throughput COR Instrument Using SurePath Screening Samples From the Danish Cervical Cancer Screening Program

Auteurs: Ditte Møller Ejegod, Helle Pedersen, Birgitte Tønnes Pedersen, Christine Monceyron Jonassen, Agnes Kathrine Lie, Laila Solhaug Hulleberg, Marc Arbyn, and Jesper Bonde
Publié dans: American Journal of Clinical Pathology, Numéro 157(3), 2021, Page(s) 390–98, ISSN 0002-9173
Éditeur: American Society for Clinical Pathology
DOI: 10.1093/ajcp/aqab138

Clinically validated <scp>HPV</scp> assays offer comparable long‐term safety in primary cervical cancer screening: A 9‐year follow‐up of a population‐based screening cohort

Auteurs: Anja Oštrbenk Valenčak, Kelsi R. Kroon, Danijela Fabjan, Jana Mlakar, Katja Seme, Johannes Berkhof, Mario Poljak
Publié dans: International Journal of Cancer, Numéro 156, 2024, Page(s) 788-801, ISSN 0020-7136
Éditeur: John Wiley & Sons Inc.
DOI: 10.1002/ijc.35200

Classification of high‐grade cervical intraepithelial neoplasia by p16 ink4a , Ki‐67, HPV E4 and FAM19A4 / miR124 ‐2 methylation status demonstrates considerable heterogeneity with potential consequences for management

Auteurs: Frederique J. Vink, Stèfanie Dick, Daniëlle A. M. Heideman, Lise M. A. De Strooper, Renske D. M. Steenbergen, Birgit I. Lissenberg‐Witte, Arno Floore, Jesper H. Bonde, Anja Oštrbenk Valenčak, Mario Poljak, Karl U. Petry, Peter Hillemanns, Nienke E. Trommel, Johannes Berkhof, Maaike C. G. Bleeker, Chris J. L. M. Meijer
Publié dans: International Journal of Cancer, Numéro 149/3, 2021, Page(s) 707-716, ISSN 0020-7136
Éditeur: John Wiley & Sons Inc.
DOI: 10.1002/ijc.33566

National Experience in the First Two Years of Primary Human Papillomavirus (HPV) Cervical Screening in an HPV Vaccinated Population in Australia: Observational Study

Auteurs: Megan A Smith., Maddison Sherrah, Farhana Sultana, Philip E. Castle, Marc Arbyn, Dorota Gertig, Michael Caruana, C. David Wrede, Marion Saville, and Karen Canfell
Publié dans: The BMJ, Numéro 376, 2022, Page(s) e068582, ISSN 1756-1833
Éditeur: BMJ
DOI: 10.1136/bmj-2021-068582

Clinical and Analytical Evaluation of the Alinity m HR HPV Assay within the VALGENT-3 Framework

Auteurs: Sharonjit K. Dhillon, Anja Oštrbenk Valenčak, Lan Xu, Mario Poljak, Marc Arbyn
Publié dans: Journal of Clinical Microbiology, Numéro 59/6, 2021, ISSN 0095-1137
Éditeur: American Society for Microbiology
DOI: 10.1128/jcm.00286-21

Risk of Cervical Intraepithelial Neoplasia Grade 3 or Worse in HPV-Positive Women with Normal Cytology and Five-Year Type Concordance: A Randomized Comparison

Auteurs: Federica Inturrisi, Johannes A. Bogaards, Daniëlle A.M. Heideman, Chris J.L.M. Meijer, Johannes Berkhof
Publié dans: Cancer Epidemiology Biomarkers & Prevention, Numéro 30/3, 2021, Page(s) 485-491, ISSN 1055-9965
Éditeur: American Association for Cancer Research
DOI: 10.1158/1055-9965.epi-20-1336

Testing for Human Papillomaviruses in Urine, Blood, and Oral Specimens: an Update for the Laboratory

Auteurs: Mario Poljak; Kate Cuschieri; Laia Alemany; Alex Vorsters
Publié dans: J Clin Microbiol, Numéro 16, 2023, ISSN 0095-1137
Éditeur: American Society for Microbiology
DOI: 10.1128/jcm.01403-22

HPV-based Cervical Cancer Screening on Self-samples in the Netherlands: Challenges to Reach Women and Test Performance Questions

Auteurs: Marc Arbyn, Stefanie Costa, Ardashel Latsuzbaia, Eliane Kellen, Paolo Girogi Rossi, Clementina E. Cocuzza, Partha Basu, Philip E. Castle
Publié dans: Cancer Epidemiology, Biomarkers & Prevention, Numéro 32, 2023, Page(s) 159-163, ISSN 1055-9965
Éditeur: American Association for Cancer Research
DOI: 10.1158/1055-9965.epi-22-1041

Baseline assessment of cervical cancer screening and treatment capacity in 25 counties in Kenya, 2022

Auteurs: Valerian Mwenda, David Murage, Catherine Kilonzo, Joan-Paula Bor, Patricia Njiri, Lance Osiro, Mary Nyangasi, Marc Arbyn, Philippe Tummers, Marleen Temmerman
Publié dans: Frontiers in Oncology, Numéro 14, 2024, ISSN 2234-943X
Éditeur: Frontiers Media S. A.
DOI: 10.3389/fonc.2024.1371529

HPV testing in Polish population-based cervical cancer screening programme (HIPPO project)—Study protocol of a randomised healthcare policy trial.

Auteurs: Glinska, P., Komerska, K., Janik, B., Olkowicz, J., Jedrzejewska, I., Macios, A., Wieszczy, P., Kaminski, M. F., Arbyn, M., & Nowakowski, A.
Publié dans: BMC Cancer, 2023, Page(s) 23(1), 1118., ISSN 1471-2407
Éditeur: BioMed Central
DOI: 10.1186/s12885-023-11597-5

Knowledge of cytology results affects the performance of colposcopy: a crossover study

Auteurs: Eva Lalande, Holly Clarke, Manuela Undurraga, Vu Quoc Huy Nguyen, Cyril Jaksic, Frederic Goffin, Marc Arbyn, Jose Jeronimo, Jean-Christophe Tille, Essia Saiji, Pierre Vassilakos, Patrick Petignat
Publié dans: BMC Women's Health, Numéro 24, 2024, ISSN 1472-6874
Éditeur: BioMed Central
DOI: 10.1186/s12905-024-03025-y

HPV and head and neck cancers: Towards early diagnosis and prevention

Auteurs: Luisa Galati, Susanna Chiocca, Daria Duca, Marta Tagliabue, Cindy Simoens, Tarik Gheit, Marc Arbyn, Massimo Tommasino
Publié dans: Tumour Virus Research, Numéro 14, 2024, Page(s) 200245, ISSN 2666-6790
Éditeur: Elsevier
DOI: 10.1016/j.tvr.2022.200245

Performance of Human Gene EPB41L3 and HPV 16/18 Viral DNA Methylation to Triage hrHPV-Positive Women

Auteurs: Remila Rezhake, Yan Wang, Xuelian Zhao, Marc Arbyn, Guqun Shen, Qinjing Pan, Xun Zhang, Yuanming Zhang, Fanghui Zhao, Youlin Qiao
Publié dans: Vaccines, Numéro 12, 2024, Page(s) 46, ISSN 2076-393X
Éditeur: Multidisciplinary Digital Publishing Institute (MDPI)
DOI: 10.3390/vaccines12010046

The Role of Methylation of Host and/or Human Papillomavirus (HPV) DNA in Management of Cervical Intraepithelial Neoplasia Grade 2 (CIN2) Lesions

Auteurs: Andraž Dovnik, Mario Poljak
Publié dans: International Journal of Molecular Sciences, Numéro 24, 2023, Page(s) 6479, ISSN 1422-0067
Éditeur: Multidisciplinary Digital Publishing Institute (MDPI)
DOI: 10.3390/ijms24076479

Methods for meta-analysis and meta-regression of binomial data: concepts and tutorial with Stata command metapreg

Auteurs: Victoria Nyawira Nyaga, Marc Arbyn
Publié dans: Archives of Public Health, Numéro 82, 2024, ISSN 2049-3258
Éditeur: Springer Medizin
DOI: 10.1186/s13690-023-01215-y

Diagnostic Accuracy of Cervical Cancer Screening Strategies for High-Grade Cervical Intraepithelial Neoplasia (CIN2+/CIN3+) among Women Living with HIV: A Systematic Review and Meta-Analysis

Auteurs: Helen Kelly, Iman Jaafar, Michael Chung, Pamela Michelow, Sharon Greene, Howard Strickler, Xianhong Xie, Mark Schiffman, Nathalie Broutet, Philippe Mayaud, Shona Dalal, Marc Arbyn, and Silvia de Sanjosé
Publié dans: EClinicalMedicine, Numéro 53, 2022, Page(s) 101645, ISSN 2589-5370
Éditeur: Oxford: Elsevier
DOI: 10.1016/j.eclinm.2022.101645

Evaluation of DNA methylation biomarkers ASCL1 and LHX8 on HPV-positive self-collected samples from primary HPV-based screening

Auteurs: Lisanne Verhoef; Maaike C. G. Bleeker; Nicole Polman; Renske D. M. Steenbergen; Renée M. F. Ebisch; Willem J. G. Melchers; Ruud L. M. Bekkers; Anco C. Molijn; Wim G. Quint; Folkert van Kemenade; Chris J. L. M. Meijer; Johannes Berkhof; Daniëlle A. M. Heideman
Publié dans: British Journal of Cancer, 2023, Page(s) 129, 1, pp. 104-111, ISSN 0007-0920
Éditeur: Nature Publishing Group
DOI: 10.1038/s41416-023-02277-z

The confounding effect of multi-type human papillomavirus infections on type-specific natural history parameter identification

Auteurs: Anna Suomenrinne-Nordvik, Simopekka Vänskä
Publié dans: Epidemics, Numéro 36, 2021, Page(s) 100468, ISSN 1755-4365
Éditeur: Elsevier BV
DOI: 10.1016/j.epidem.2021.100468

Quality assurance in human papillomavirus testing for primary cervical screening

Auteurs: Kate Cuschieri; María Dolores Fellner; Laila Sara Arroyo Mühr; Elizaveta Padalko; Rita Mariel Correa; Joakim Dillner; Murat Gultekin; Maria Alejandra Picconi
Publié dans: Int J Gynecol Cancer, 2023, ISSN 1048-891X
Éditeur: Blackwell Publishing Inc.
DOI: 10.1136/ijgc-2022-004197

Concomitant Human Papillomavirus (HPV) Vaccination and HPV Screening for Rapid Elimination of HPV Infection and Cervical Cancer

Auteurs: Joakim Dillner, Laila Sara Arroyo Muhr, Andrea Gini, Emel Yilmaz, Sadaf Hassan, Camilla Lagheden, Emilie Hultin, Ainhoa Garcia Serrano, Agustin Ure, Helena Andersson, Roxana Martinez Merino, K. Elfström, Iacopo Baussano
Publié dans: Nature communications, Numéro 15, 2024, Page(s) 3679, ISSN 2041-1723
Éditeur: Nature Publishing Group
DOI: 10.21203/rs.3.rs-3339493/v1

2023 global inventory of commercial molecular tests for human papillomaviruses (HPV)

Auteurs: Poljak, M., Oštrbenk Valenčak, A., Cuschieri, K., Bohinc, K. B., & Arbyn, M.
Publié dans: Journal of Clinical Virology,, 2024, Page(s) 172, 105671., ISSN 1386-6532
Éditeur: Elsevier BV
DOI: 10.1016/j.jcv.2024.105671

Commercially available molecular tests for human papillomaviruses: a global overview

Auteurs: M. Poljak, A. Oštrbenk Valenčak, G. Gimpelj Domjanič, L. Xu, M. Arbyn
Publié dans: Clinical Microbiology and Infection, Numéro 26/9, 2020, Page(s) 1144-1150, ISSN 1198-743X
Éditeur: Blackwell Publishing Inc.
DOI: 10.1016/j.cmi.2020.03.033

Clinical and analytical performance of the CLART HPV 4S assay with SurePath screening samples from the Danish cervical cancer screening program using the VALGENT framework

Auteurs: Ditte Møller Ejegod, Helle Pedersen, Wim Quint, Lan Xu, Marc Arbyn, Jesper Hansen Bonde
Publié dans: Journal of Virological Methods, Numéro 292, 2021, Page(s) 114118, ISSN 0166-0934
Éditeur: Elsevier BV
DOI: 10.1016/j.jviromet.2021.114118

Self‐sampling as the Principal Modality for Population Based Cervical Screening: Five‐year Follow‐up of the PaVDaG Study

Auteurs: Grazyna A. Stanczuk, Heather Currie, William Forson, Gwendoline Baxter, James Lawrence, Allan Wilson, Timothy Palmer, Marc Arbyn, and Kate Cuschieri.
Publié dans: International Journal of Cancer, Numéro 150(8), 2022, Page(s) 1350–56, ISSN 0020-7136
Éditeur: John Wiley & Sons Inc.
DOI: 10.1002/ijc.33888

Performance of BD Onclarity HPV assay on FLOQSwabs vaginal self-samples

Auteurs: Marianna Martinelli, Ardashel Latsuzbaia, Jesper Bonde, Helle Pedersen, Anna D. Iacobone, Fabio Bottari, Andrea F. Piana, Roberto Pietri, Clementina E. Cocuzza, Marc Arbyn, Chiara Giubbi, Si Brask Sonne, Emilie Korsgaard Andrease, Silvia Martella, Eleonora Petra Preti, Maria Elena Guerrieri, Rita Passerini, Narcisa Muresu, Illari Sechi, Arianna Dettori, Maria Eugenia Ghi, Maria Paola Bagella, Adri
Publié dans: Microbiology Spectrum, Numéro 12, 2024, ISSN 2165-0497
Éditeur: ASM Joournal
DOI: 10.1128/spectrum.02872-23

Study Protocol: Randomised Controlled Trial Assessing the Efficacy of Strategies Involving Self-Sampling in Cervical Cancer Screening

Auteurs: Caroline Lefeuvre, Hélène De Pauw, Anne-Sophie Le Duc Banaszuk, Adeline Pivert, Alexandra Ducancelle, Franck Rexand-Galais, and Marc Arbyn
Publié dans: International Journal of Public Health, Numéro 67, 2022, Page(s) 1604284, ISSN 1661-8556
Éditeur: Birkhauser Verlag
DOI: 10.3389/ijph.2022.1604284

Geographic and Temporal Variations in the Incidence of Vulvar and Vaginal Cancers

Auteurs: Freddie Bray, Mathieu Laversanne, Elisabete Weiderpass, and Marc Arbyn
Publié dans: International Journal of Cancer, Numéro 147(10), 2020, Page(s) 2764–71, ISSN 0020-7136
Éditeur: John Wiley & Sons Inc.
DOI: 10.1002/ijc.33055

Tackling cervical cancer in Europe amidst the COVID-19 pandemic

Auteurs: Marc Arbyn, Laia Bruni, Daniel Kelly, Partha Basu, Mario Poljak, Murat Gultekin, Christine Bergeron, David Ritchie, Elisabete Weiderpass
Publié dans: The Lancet Public Health, Numéro 5/8, 2020, Page(s) e425, ISSN 2468-2667
Éditeur: Elsevier
DOI: 10.1016/s2468-2667(20)30122-5

Cervical Cancer Screening Programmes and Age-Specific Coverage Estimates for 202 Countries and Territories Worldwide: A Review and Synthetic Analysis

Auteurs: Laia Bruni, Beatriz Serrano, Esther Roura, Laia Alemany, Melanie Cowan, Rolando Herrero, Mario Poljak, Raul Murillo, Nathalie Broutet, Leanne M. Riley, and Silvia de Sanjose
Publié dans: The Lancet. Global Health, Numéro 10(8), 2022, Page(s) e1115–27, ISSN 2214-109X
Éditeur: Elsevier BV
DOI: 10.1016/s2214-109x(22)00241-8

Clinical performance of the novel full‐genotyping <scp>OncoPredict HPV</scp> Quantitative Typing assay using the <scp>VALGENT</scp> framework

Auteurs: Clementina Elvezia Cocuzza, Sharonjit Kaur Dhillon, Marianna Martinelli, Chiara Giubbi, Ruth Chinyere Njoku, Ramya Bhatia, Kate Cuschieri, Marc Arbyn
Publié dans: International Journal of Cancer, Numéro 154, 2023, Page(s) 538-547, ISSN 0020-7136
Éditeur: John Wiley & Sons Inc.
DOI: 10.1002/ijc.34754

Estimating the direct effect of human papillomavirus vaccination on the lifetime risk of screen‐detected cervical precancer

Auteurs: Federica Inturrisi, Birgit I. Lissenberg‐Witte, Nienke J. Veldhuijzen, Johannes A. Bogaards, Guglielmo Ronco, Chris J. L. M. Meijer, Johannes Berkhof
Publié dans: International Journal of Cancer, Numéro 148/2, 2021, Page(s) 320-328, ISSN 0020-7136
Éditeur: John Wiley & Sons Inc.
DOI: 10.1002/ijc.33207

Staged design recommendations for validating relative sensitivity of self-sample human papillomavirus tests for cervical screening

Auteurs: Adam R. Brentnall, Kate Cuschieri, Alexandra Sargent, Johannes Berkhof, Matejka Rebolj
Publié dans: Journal of Clinical Epidemiology, Numéro 166, 2024, Page(s) 111227, ISSN 0895-4356
Éditeur: Elsevier BV
DOI: 10.1016/j.jclinepi.2023.111227

DNA methylation as a triage tool for cervical cancer screening – A meeting report

Auteurs: F. Ricardo Burdier, Dur-e-Nayab Waheed, Belinda Nedjai, Renske D.M. Steenbergen, Mario Poljak, Marc Baay, Alex Vorsters, Severien Van Keer
Publié dans: Preventive Medicine Reports, Numéro 41, 2024, Page(s) 102678, ISSN 2211-3355
Éditeur: Elsevier BV
DOI: 10.1016/j.pmedr.2024.102678

Europe’s Path to Eliminating Cervical Cancer as a Public Health Problem

Auteurs: David Ritchie, Marc Arbyn, Partha Basu, Marilys Corbex, Elena Fidarova, Urska Ivanuš, Ginevra Papi, Julie Torode, and Chrysoula Zacharopoulou
Publié dans: The Lancet Regional Health - Europe, Numéro 12, 2021, Page(s) 100276, ISSN 2666-7762
Éditeur: Oxford: Elsevier Ltd.
DOI: 10.1016/j.lanepe.2021.100276

Characterization and Diversity of 243 Complete Human Papillomavirus Genomes in Cervical Swabs Using Next Generation Sequencing

Auteurs: Ardashel Latsuzbaia, Anke Wienecke-Baldacchino, Jessica Tapp, Marc Arbyn, Irma Karabegović, Zigui Chen, Marc Fischer, Friedrich Mühlschlegel, Steven Weyers, Pascale Pesch, Joël Mossong
Publié dans: Viruses, Numéro 12/12, 2020, Page(s) 1437, ISSN 1999-4915
Éditeur: Multidisciplinary Digital Publishing Institute (MDPI)
DOI: 10.3390/v12121437

The European response to the WHO call to eliminate cervical cancer as a public health problem

Auteurs: Marc Arbyn, Murat Gultekin, Philippe Morice, Pekka Nieminen, Maggie Cruickshank, Philip Poortmans, Daniel Kelly, Mario Poljak, Christine Bergeron, David Ritchie, Dietmar Schmidt, Maria Kyrgiou, Ann Van den Bruel, Laia Bruni, Partha Basu, Freddie Bray, Elisabete Weiderpass
Publié dans: International Journal of Cancer, Numéro 148/2, 2021, Page(s) 277-284, ISSN 0020-7136
Éditeur: John Wiley & Sons Inc.
DOI: 10.1002/ijc.33189

Evaluation of the Allplex HPV assay’s adherence to international guidelines for cervical cancer screening in clinician-collected samples

Auteurs: Pui Yan Jenny Chung, Sharonjit K. Dhillon, Selina Cortoos, Hannelore Hamerlinck, Rita Pereira, Elizaveta Padalko, Davy Vanden Broeck, Marc Arbyn
Publié dans: Microbiology Spectrum, Numéro 12, 2024, ISSN 2165-0497
Éditeur: American Society for Microbiology
DOI: 10.1128/spectrum.00332-24

Clinical evaluation of primary human papillomavirus (HPV) testing with extended <scp>HPV</scp> genotyping triage for cervical cancer screening: A pooled analysis of individual patient data from nine population‐based cervical cancer screening studies from China

Auteurs: Changchang Dun, Meiwen Yuan, Xuelian Zhao, Shangying Hu, Marc Arbyn, Fanghui Zhao
Publié dans: Cancer Medicine, Numéro 13, 2024, ISSN 2095-3941
Éditeur: Chinese Anticancer Association
DOI: 10.1002/cam4.7316

Intra‐ and interlaboratory reproducibility of the RIATOL qPCR HPV genotyping assay

Auteurs: Sharonjit K. Dhillon, Pui Yan Jenny Chung, Elizaveta Padalko, Marleen Praet, Ana Rita Pereira, Nina Redzic, Davy Vanden Broeck, Marc Arbyn
Publié dans: Journal of Medical Virology, Numéro 95, 2023, ISSN 0146-6615
Éditeur: John Wiley & Sons Inc.
DOI: 10.1002/jmv.29093

Allplex HPV HR Detection assay fulfils all clinical performance and reproducibility validation requirements for primary cervical cancer screening

Auteurs: Anja Oštrbenk Valenčak, Kate Cuschieri, Linzi Connor, Andrej Zore, Špela Smrkolj, Mario Poljak
Publié dans: Journal of Clinical Virology, Numéro 170, 2024, Page(s) 105638, ISSN 1386-6532
Éditeur: Elsevier BV
DOI: 10.1016/j.jcv.2023.105638

2020 list of human papillomavirus assays suitable for primary cervical cancer screening

Auteurs: Marc Arbyn, Marie Simon, Eliana Peeters, Lan Xu, Chris J.L.M. Meijer, Johannes Berkhof, Kate Cuschieri, Jesper Bonde, Anja Ostrbenk Vanlencak, Fang-Hui Zhao, Remila Rezhake, Murat Gultekin, Joakim Dillner, Silvia de Sanjosé, Karen Canfell, Peter Hillemanns, Maribel Almonte, Nicolas Wentzensen, Mario Poljak
Publié dans: Clinical Microbiology and Infection, Numéro 2021 May 8:S1198-743X(21)00219-6., 2021, ISSN 1198-743X
Éditeur: Blackwell Publishing Inc.
DOI: 10.1016/j.cmi.2021.04.031

Acceptability to Healthcare Professionals of Home-Based HPV Self-Sampling for Cervical Screening: A French Qualitative Study Conducted in an Area with Low Access to Health Services

Auteurs: Johane Le Goff; Anne-Sophie Le Duc-Banaszuk; Caroline Lefeuvre; Adeline Pivert; Alexandra Ducancelle; Hélène De Pauw; Marc Arbyn; Aubeline Vinay; Franck Rexand-Galais
Publié dans: Cancers, 2023, ISSN 2072-6694
Éditeur: Multidisciplinary Digital Publishing Institute (MDPI)
DOI: 10.3390/cancers15215163

Clinical Validation of the Fully Automated NeuMoDx HPV Assay for Cervical Cancer Screening

Auteurs: Daniëlle A Heideman. M., Anja Oštrbenk Valenčak, Saskia Doorn, Jesper Bonde, Peter Hillemanns, Grega Gimpelj Domjanič, Jana Mlakar, Albertus T. Hesselink, Chris J. L. M. Meijer, and Mario Poljak
Publié dans: Viruses, Numéro 14(5), 2022, Page(s) 893, ISSN 1999-4915
Éditeur: Multidisciplinary Digital Publishing Institute (MDPI)
DOI: 10.3390/v14050893

Triage Options to Manage High-Risk Human Papillomavirus-Positive Women: A Population-Based Cross-Sectional Study from Rural China

Auteurs: Remila Rezhake, Feng Chen, Shang-Ying Hu, Xue-Lian Zhao, Xun Zhang, Jian Cao, You-Lin Qiao, Fang-Hui Zhao, and Marc Arbyn.
Publié dans: International Journal of Cancer, Numéro 147(8), 2020, Page(s) 2053–64, ISSN 0020-7136
Éditeur: John Wiley & Sons Inc.
DOI: 10.1002/ijc.33001

HPV-BASED CERVICAL CANCER SCREENING: FROM ‘ONE-SIZE-FITS-ALL’ TOWARDS RISK-BASED STRATEGIES

Auteurs: Inturrisi, Federica
Publié dans: Numéro 28, 2021
Éditeur: Vrije Univesiteit Amsterdam

A framework for meta-analysis through standardized survival curves

Auteurs: Hautekiet, Joris; Prigge, Elena-Sophie; Obermueller, Theresa; Arbyn, Marc; Goetghebeur, Els
Publié dans: ArXiv (pre-print), Numéro 17, 2021, ISSN 2331-8422
Éditeur: Cornell University
DOI: 10.48550/arxiv.2111.13132

Recherche de données OpenAIRE...

Livrables

Publications

Partager cette page

Télécharger